ROCHE HOLDING AG News

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)

TipRanksFeb 24 07:10 ET · Ratings

Swiss Market Index Hits All-Time High -- Market Talk

WSJFeb 24 06:24 ET

Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News

Seeking AlphaFeb 22 09:59 ET

Express News | FDA Says Semaglutide Injection Shortage Is Resolved As Of Feb 21

BenzingaFeb 21 09:22 ET

Pfizer Said to Be Discontinuing Roche-partnered Hemophilia Therapy Beqvez

Seeking AlphaFeb 20 15:15 ET

Bernstein Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

TipRanksFeb 20 07:07 ET · Ratings

Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership With Roche

BusinesswireFeb 18 14:03 ET

Roche Holding AG Falls Monday, Underperforms Market

Dow JonesFeb 17 12:17 ET

Roche Elecsys SFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Reliable Way to Predict the Risk of Developing Severe Preeclampsia

PR NewswireFeb 13 09:00 ET

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

WSJFeb 13 06:43 ET

Roche Holding Raised to Buy From Neutral by UBS

Dow JonesFeb 13 04:15 ET · Ratings

Roche Holding Target Raised to CHF338 From CHF300 by UBS

Dow JonesFeb 13 04:15 ET · Ratings

FDA Approves Genentech's Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)

BusinesswireFeb 12 11:45 ET

Zhongtai International: Maintains INNOVENT BIO 'Buy' rating, Target Price raised to HKD 43.85.

Zhuhai International released a research report stating that it maintains its "Buy" rating for INNOVENT BIO (01801), with the Target Price raised from HKD 42.45 to HKD 43.85 based on the adjusted DCF model. The company expects that the initial launch of Ma Shidu Peptide may increase sales promotions, and therefore, the sales expense forecast for 2025E has been raised by 9.3%. However, due to an increase in total revenue forecasts, the Shareholder Net income forecasts for 2025-26E have been raised by 0.1% and 4.6% respectively. Zhuhai International's main points are as follows: The company's product sales revenue is expected to grow rapidly in 2024 as planned, as recently announced for the full-year product sales in 2024.

新浪港股Feb 11 22:59 ET

Amazon has opened its first beauty and health products store in Milan, Italy.

Amazon, the giant e-commerce company from the USA, will open a store for beauty and health products in Milan, Italy, marking the company's latest experiment with physical stores. In a blog post, Amazon stated that this store is located in downtown Milan and primarily sells a range of beauty and Personal Care products, as well as over-the-counter medications. The first store, named Amazon Parafarmacia & Beauty, will be open to the public on Wednesday. The store will sell products from beauty and skincare brands including La Roche-Posay, Eucerin, and Vichy.

Global market broadcast.Feb 11 18:36 ET

Roche Holding AG Falls Tuesday, Underperforms Market

Dow JonesFeb 11 12:17 ET

TD Cowen Maintains ROCHE HOLDING AG(RHHBY.US) With Hold Rating, Maintains Target Price $43

Moomoo NewsFeb 10 23:32 ET · Ratings

Is Roche Holding AG (RHHBY) The Best Annual Dividend Stock To Buy Now?

Yahoo FinanceFeb 10 18:24 ET

Roche Holding AG Rises Monday

Dow JonesFeb 10 12:17 ET

Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)

TipRanksFeb 10 05:35 ET · Ratings